Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.

This low level of administered enoxaparin is concerning in a patient population at an increased risk for VTE. VTE prophylaxis adherence needs to be addressed with each admission and, if appropriate, alterative options to enoxaparin should be considered.